Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
30
2014
The Race is on! Anxiously Waiting for the First U.S. Biosimilar to Cross the Finish Line Michael Best & Friedrich LLP
Feb
6
2015
Is Compulsory Licensing of Generic Medicines Coming to the Russian Federation? Michael Best & Friedrich LLP
Sep
18
2015
Indian Patent Office Rejects Pfizer’s Patent for Tofacitinib – Again! Michael Best & Friedrich LLP
Aug
19
2016
Updates to the Brazilian Food and Drug Administration OTC Drug Guidelines Michael Best & Friedrich LLP
Apr
26
2017
New Guidelines in Brazil Give More Power to ANVISA in Examination of Pharmaceutical Patent Applications Michael Best & Friedrich LLP
Nov
13
2010
USPTO Extends and Expands the Green Technology Pilot Program Michael Best & Friedrich LLP
Sep
10
2013
Understanding Biologics and Biosimilars in Brazil Michael Best & Friedrich LLP
May
29
2014
An Overview of Biosimilars in the Russian Federation Michael Best & Friedrich LLP
Jun
13
2014
Cloning: It’s not what you think – Changes to ANVISA’s (Brazil Health Service Agency) “Clone” Procedure Michael Best & Friedrich LLP
Jun
25
2014
Is an Abbreviated Pathway for Biosimilars Coming Soon to China? Michael Best & Friedrich LLP
Jun
15
2015
Ariosa Diagnostics, Inc. v. Sequenom, Inc. – Another Diagnostic Patent Meets its End Michael Best & Friedrich LLP
Oct
28
2015
Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca’s Patent Covering Fosladex Invalid Michael Best & Friedrich LLP
Dec
10
2015
Biologics and Biosimilars Bits and Bytes – December 10, 2015 Michael Best & Friedrich LLP
Aug
23
2017
Understanding Bolar and Bolar-Like Exceptions in the U.S. and Abroad – Part 2 – Canada Michael Best & Friedrich LLP
Aug
29
2010
States to Re-evaluate Feed-in Tariffs After Recent FERC Ruling Michael Best & Friedrich LLP
Nov
14
2010
EPA Issues Guidance on Permitting for GHG Emissions Michael Best & Friedrich LLP
Jan
18
2011
EPA Defers GHG Permitting Requirements for Biomass Industries Michael Best & Friedrich LLP
Feb
28
2013
High Impact Entrepreneurship in Wisconsin: The Smoke and the Fire Michael Best & Friedrich LLP
Apr
26
2013
Expanding Market for Technologies to Clean Wastewater from Hydraulic Fracturing Michael Best & Friedrich LLP
Feb
25
2014
Phosphorus Legislation Passes Both Wisconsin Houses Michael Best & Friedrich LLP
May
21
2014
An Overview of Biosimilars and the Biosimilar Pathway in India Michael Best & Friedrich LLP
Sep
3
2015
Update in Amgen v. Sandoz re: Biosimilar Applications Michael Best & Friedrich LLP
Dec
30
2015
Current State of Data Protection and Exclusivity in Russia Michael Best & Friedrich LLP
Jun
30
2016
USPTO Launches Cancer Immunotherapy Pilot Program Michael Best & Friedrich LLP
Jan
17
2017
Federal Circuit’s Eli Lilly Decision Clarifies the Direction or Control Standard in Dividend Infringement Michael Best & Friedrich LLP
May
1
2017
Appropriations Rider Halts FDA’s Voluntary Sodium Reduction Efforts Michael Best & Friedrich LLP
Sep
13
2010
Wisconsin Public Service Commission Approves Administrative Rule to Site and Permit Wind Farms Michael Best & Friedrich LLP
Jan
25
2011
CleanTech Opportunities On The Rise Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins